NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 33 filers reported holding NEUROBO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $11,000 | -88.8% | 24,056 | -18.7% | 0.00% | – |
Q2 2021 | $98,000 | -46.7% | 29,576 | -15.5% | 0.00% | – |
Q4 2020 | $184,000 | -51.6% | 34,987 | -48.3% | 0.00% | – |
Q3 2020 | $380,000 | -55.9% | 67,616 | -36.8% | 0.00% | -100.0% |
Q2 2020 | $861,000 | -33.7% | 106,922 | +5.4% | 0.00% | -66.7% |
Q1 2020 | $1,299,000 | – | 101,418 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 182,543 | $1,026,000 | 0.15% |
Hayden Royal, LLC | 22,682 | $127,000 | 0.07% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 6,454 | $36,000 | 0.00% |
UBS Group AG | 1,913 | $11,000 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 2,559 | $14,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 2,012 | $11,000 | 0.00% |
Russell Investments Group, Ltd. | 28,597 | $160,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 1,337 | $7,000 | 0.00% |
NORTHERN TRUST CORP | 85,444 | $479,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |